Formulation and Drug Delivery, Parenterals

Exploring Innovative Means for Biologics Delivery

September 10, 2024

Alternative delivery methods for biologics continues to be explored that offer less invasive, less painful administration.

Takeda’s Subcutaneous Immunoglobulin Receives FDA Approval for Maintenance Therapy of Rare Neuromuscular Disorder

January 24, 2024

Takeda has received FDA approval for HYQVIA, a subcutaneous immunoglobulin for the maintenance treatment of chronic inflammatory demyelinating polyneuropathy.

Nanoparticle Engineering in Drug Delivery Under the Microscope

September 02, 2023

Nanoparticles offer the potential for a safer, more effective method of drug delivery to the patient.

Takeda Gets Approval in Japan for Entyvio Subcutaneous Injection

March 30, 2023

Takeda received approval in Japan for a subcutaneous injection formulation of Entyvio (vedolizumab) for treating ulcerative colitis.

Catalent Licenses Bhami Research Laboratory Technology for Biologics Formulation Development

March 17, 2023

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Considerations for a Successful Reformulation Strategy

November 08, 2022

Companies need to consider and address formulation challenges to employ a successful reformulation strategy.

Reformulating Success

October 02, 2022

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

Accelerating the Development of mRNA Therapeutics

September 16, 2022

Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.

Advances in Drug Delivery and Areas for Improvement

September 02, 2022

While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.

Deciding Where to Outsource in Biopharma Development and Manufacturing

August 02, 2022

Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.